Taiwan Stock Exchange · Consumer Defensive
Kuangli Bio-Tech Holdings stock from India: price, numbers and tax
Kuangli Bio-Tech Holdings (6431) is not currently available to trade on Paasa; this guide covers the price, the numbers and the Indian tax treatment.
By Paasa · Updated
Kuangli Bio-Tech Holdings at a glance
- Price
- NT$16.80-NT$0.20 (1.18%)
- Market cap
- NT$1.64B
- Day range
- NT$16.40 – NT$16.80
- P/E
- -8.48
- Dividend yield
- None
- Volume
- 108.93K
- 1 month
- -7.95%
- 6 months
- -26.96%
- YTD
- -37.55%
- 1 year
- +5.00%
- 5 years
- -43.34%
Kuangli Bio-Tech Holdings statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | NT$377.0M | NT$381.3M | NT$293.4M | NT$342.2M | NT$358.2M |
| Gross profit | NT$70.4M | NT$68.3M | NT$66.3M | NT$68.7M | NT$91.5M |
| Operating income | −NT$157.5M | −NT$138.1M | −NT$113.7M | −NT$70.2M | NT$64.7M |
| Net income | −NT$193.0M | −NT$172.8M | −NT$104.2M | −NT$71.0M | NT$55.9M |
| Earnings per share | −NT$2.07 | −NT$2.52 | −NT$1.82 | −NT$1.26 | NT$1.10 |
| EBITDA | −NT$92.5M | −NT$82.6M | −NT$48.9M | −NT$9.5M | NT$107.5M |
| Total assets | NT$1.2B | NT$910.2M | NT$1.0B | NT$1.1B | NT$1.2B |
| Total debt | NT$487.3M | NT$336.8M | NT$421.5M | NT$349.8M | NT$348.3M |
| Cash and short-term investments | NT$310.2M | NT$41.6M | NT$90.8M | NT$163.0M | NT$183.0M |
| Shareholders' equity | NT$577.4M | NT$460.0M | NT$557.9M | NT$672.7M | NT$482.3M |
| Operating cash flow | −NT$145.3M | −NT$65.2M | −NT$62.4M | −NT$9.2M | NT$21.7M |
| Free cash flow | −NT$154.5M | −NT$82.7M | −NT$87.6M | −NT$43.5M | −NT$18.9M |
| Capital expenditure | −NT$9.1M | −NT$17.4M | −NT$25.2M | −NT$34.2M | −NT$40.6M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in TWD; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Mikobeaute International | 6574.TWO | $123.00 | $2.70B |
| Grand Hall Enterprise | 8941.TWO | $43.25 | $1.51B |
| Jourdeness | 4190.TW | NT$24.50 | NT$1.45B |
| San Neng | 6671.TW | NT$23.05 | NT$1.40B |
| Far East Bio-Tec | 6886.TWO | $42.50 | $1.35B |
| Samebest | 8489.TWO | $21.90 | $1.31B |
| DaBomb Protein Biotech | 6578.TWO | $16.65 | $1.20B |
| Mao Bao | 1732.TW | NT$28.00 | NT$1.19B |
Peers as grouped by the data provider. This is not an investment recommendation.
Why invest in Kuangli Bio-Tech Holdings from India
What Kuangli Bio-Tech Holdings does
Kuangli Photoelectric Technology Co., Ltd. specializes in the production and distribution of cover lens panels tailored for a wide array of electronic devices. These critical components are integrated into numerous products, including protective screens for mobile phones and laptops, cameras, decorative elements, buttons, and touch panels for tablet PCs and other consumer electronics. Kuangli Bio-Tech Holdings operates in the Household & Personal Products industry within the Consumer Defensive sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
How are Kuangli Bio-Tech Holdings dividends taxed for Indian investors?
Kuangli Bio-Tech Holdings trades on the Taiwan Stock Exchange but is domiciled in Cayman Islands, so any withholding on its dividends follows that country's rules rather than those of Taiwan. Dividends are taxed at your slab rate in India.
What tax do I pay in India when I sell Kuangli Bio-Tech Holdings shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the TWD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain.